FR2705234B1 - Utilisation de molécules reconnues par des autoanticorps de sérums humains pour le diagnostic ou le traitement du SIDA. - Google Patents

Utilisation de molécules reconnues par des autoanticorps de sérums humains pour le diagnostic ou le traitement du SIDA.

Info

Publication number
FR2705234B1
FR2705234B1 FR9306071A FR9306071A FR2705234B1 FR 2705234 B1 FR2705234 B1 FR 2705234B1 FR 9306071 A FR9306071 A FR 9306071A FR 9306071 A FR9306071 A FR 9306071A FR 2705234 B1 FR2705234 B1 FR 2705234B1
Authority
FR
France
Prior art keywords
autoantibodies
aids
diagnosis
treatment
human sera
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9306071A
Other languages
English (en)
Other versions
FR2705234A1 (fr
Inventor
Geffard Michel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR9306071A priority Critical patent/FR2705234B1/fr
Priority to PCT/FR1994/000597 priority patent/WO1994027151A1/fr
Publication of FR2705234A1 publication Critical patent/FR2705234A1/fr
Application granted granted Critical
Publication of FR2705234B1 publication Critical patent/FR2705234B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FR9306071A 1993-05-19 1993-05-19 Utilisation de molécules reconnues par des autoanticorps de sérums humains pour le diagnostic ou le traitement du SIDA. Expired - Fee Related FR2705234B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR9306071A FR2705234B1 (fr) 1993-05-19 1993-05-19 Utilisation de molécules reconnues par des autoanticorps de sérums humains pour le diagnostic ou le traitement du SIDA.
PCT/FR1994/000597 WO1994027151A1 (fr) 1993-05-19 1994-05-19 Utilisation de molecules reconnues par des autoanticorps de serums humains pour le diagnostic ou le traitement du sida

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9306071A FR2705234B1 (fr) 1993-05-19 1993-05-19 Utilisation de molécules reconnues par des autoanticorps de sérums humains pour le diagnostic ou le traitement du SIDA.

Publications (2)

Publication Number Publication Date
FR2705234A1 FR2705234A1 (fr) 1994-11-25
FR2705234B1 true FR2705234B1 (fr) 1995-08-04

Family

ID=9447309

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9306071A Expired - Fee Related FR2705234B1 (fr) 1993-05-19 1993-05-19 Utilisation de molécules reconnues par des autoanticorps de sérums humains pour le diagnostic ou le traitement du SIDA.

Country Status (2)

Country Link
FR (1) FR2705234B1 (fr)
WO (1) WO1994027151A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2727117A1 (fr) * 1994-11-18 1996-05-24 Geffard Michel Utilisation de conjugues de la polylysine pour la preparation de medicaments utiles dans le traitement des maladies neurodegeneratives et des affections degeneratives a caractere autoimmun
JP2014514304A (ja) * 2011-04-12 2014-06-19 ネステク ソシエテ アノニム 消化管のバリア機能を改善するための、分枝鎖脂肪酸を含む栄養組成物及びその使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681870A (en) * 1985-01-11 1987-07-21 Imre Corporation Protein A-silica immunoadsorbent and process for its production
WO1989005455A1 (fr) * 1987-12-02 1989-06-15 The Regents Of The University Of California Test d'anticorps anti cellules t relatif au sida
EP0346091A3 (fr) * 1988-06-10 1990-09-12 Dana Farber Cancer Institute Procédé de diagnostic pour anticorps naturels contre cd4
JPH04503008A (ja) * 1989-01-31 1992-06-04 アイデック・ファーマシュウティカルズ・コーポレーション ひとリンパ腫および自己抗体により発現する共通イディオタイプ反応性抗―イディオタイプ抗体
US5252556A (en) * 1990-03-30 1993-10-12 New England Medical Center Hospitals, Inc. Fragment capable of binding anti-CD43 autoantibodies
EP1152243A1 (fr) * 1990-05-21 2001-11-07 The Administrators Of The Tulane Educational Fund Diagnose du sydrome de Sjögren, du lupus érythémateux disséminé, et de la scleroderme, par la detection des anticorps anti-retroviraux
US5230887A (en) * 1990-07-11 1993-07-27 Immune Network Research Ltd. Immune system stabilizers for prevention and therapy of disorders associated with immune system disfunction

Also Published As

Publication number Publication date
WO1994027151A1 (fr) 1994-11-24
FR2705234A1 (fr) 1994-11-25

Similar Documents

Publication Publication Date Title
DE3785409D1 (de) Vorrichtung zur untersuchung von ortsveraenderlichen medien mittels ultraschall-echographie.
DE69529307D1 (de) Ultraschall-Diagnose- und Behandlungssystem
DE69334246D1 (de) Verbesserte reagentien und methoden zur diagnose und behandlung von diabetes und stiff man syndrome
FR2718037B1 (fr) Appareil de traitement de tumeur.
FR2591116B1 (fr) Appareil de traitement par hyperthermie.
DE59600309D1 (de) Vorrichtung zur Behandlung von Flüssigkeiten, insbesondere von Blut
FR2600521B1 (fr) Appareil de lithotritie ultrasonore.
DE69017799D1 (de) Ultraschall-Diagnosegerät.
FR2663044B1 (fr) Appareil pour le traitement de surfaces.
ATE247504T1 (de) Vorrichtung zur behandlung des menschlichen körpers durch endermatische elektrotherapie
DE3850660D1 (de) Ultraschall-diagnosevorrichtung.
DE69310281D1 (de) Medizinisches Diagnosegerät zur Erkennung von Erkrankungen des Gehirns
DE3782214D1 (de) Mittel zur behandlung des scheidenmilieus.
ATE180494T1 (de) Nukleinsäure-bindende oligomere mit c-verzweigung für therapie und diagnostik
DZ2094A1 (fr) Appareil catalytique et/ou de filtration.
DE69010923D1 (de) Ultraschalldiagnosegerät.
FR2705234B1 (fr) Utilisation de molécules reconnues par des autoanticorps de sérums humains pour le diagnostic ou le traitement du SIDA.
DZ2012A1 (fr) Benzamides pour le traitement de dégénérescences neurologiques.
FR2607350B1 (fr) Instrument combine de broyage ou de defrichage, de decompactage et de travail du sol
FR2600531B1 (fr) Appareil pour le traitement d'etats pathologiques par stimulation de points d'acupuncture.
FR2715850B1 (fr) Système de traitement des déchets hospitaliers.
FR2708191B1 (fr) Appareil de thérapie pour le traitement au moyen d'ondes acoustiques.
FR2718958B3 (fr) Dispositif pour le traitement du corps humain.
IL85358A0 (en) Optimal parametric signal processor for least squares finite impulse response filtering
DE69016135D1 (de) Diagnostikgerät zur funktionellen Untersuchung des Kreislaufsystems.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20090119